Loading…
Review of management priorities for invasive infections in people who inject drugs: highlighting the need for patient‐centred multidisciplinary care
Summary There has been a global increase in the burden of invasive infections in people who inject drugs (PWID). It is essential that patient‐centred multidisciplinary care is provided in the management of these infections to engage PWID in care and deliver evidence‐based management and preventive s...
Saved in:
| Published in: | Medical journal of Australia 2022-07, Vol.217 (2), p.102-109 |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c4203-53865661c89e3f15dd1ebc8dc8e857f7e6459c82f60e5f0ee106cd49fd19e9e93 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c4203-53865661c89e3f15dd1ebc8dc8e857f7e6459c82f60e5f0ee106cd49fd19e9e93 |
| container_end_page | 109 |
| container_issue | 2 |
| container_start_page | 102 |
| container_title | Medical journal of Australia |
| container_volume | 217 |
| creator | Attwood, Lucy O McKechnie, Megan Vujovic, Olga Higgs, Peter Lloyd‐Jones, Martyn Doyle, Joseph S Stewardson, Andrew J |
| description | Summary
There has been a global increase in the burden of invasive infections in people who inject drugs (PWID).
It is essential that patient‐centred multidisciplinary care is provided in the management of these infections to engage PWID in care and deliver evidence‐based management and preventive strategies.
The multidisciplinary team should include infectious diseases, addictions medicine (inclusive of alcohol and other drug services), surgery, psychiatry, pain specialists, pharmacy, nursing staff, social work and peer support workers (where available) to help address the comorbid conditions that may have contributed to the patient’s presentation.
PWID have a range of antimicrobial delivery options that can be tailored in a patient‐centred manner and thus are not limited to prolonged hospital admissions to receive intravenous antimicrobials for invasive infections. These options include discharge with outpatient parenteral antimicrobial therapy, long‐acting lipoglycopeptides (dalbavancin and oritavancin) and early oral antimicrobials.
Open and respectful discussion with PWID including around harm reduction strategies may decrease the risk of repeat presentations with injecting‐related harms. |
| doi_str_mv | 10.5694/mja2.51623 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9539935</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2681442488</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4203-53865661c89e3f15dd1ebc8dc8e857f7e6459c82f60e5f0ee106cd49fd19e9e93</originalsourceid><addsrcrecordid>eNp9kc9u1DAQxi0EotvChQdAPiKkLbEdOwkHpKrir4qQEEjcLNcZJ14ldrCTXfXGI_TEA_IkTHdLBRdkWTNjf_p5xh8hT1hxKlVTvhg3hp9Kpri4R1ZMcLWWoqruk1VRcLmuePPtiBznvMGSSV49JEdCVrJkZbkiPz_D1sOORkdHE0wHI4SZTsnH5GcPmbqYqA9bk_0WMHFgZx9DxpROEKcB6K6PWG3wgrZp6fJL2vuuH3DPPnR07oEGgHZPmgxCw_zrx7XFkPB0XIbZtz5bPw0-mHRFrUnwiDxwZsjw-DaekK9vXn85f7e--PT2_fnZxdqWvBA4Z62kUszWDQjHZNsyuLR1a2uoZeUqUKVsbM2dKkC6AoAVyrZl41rWAC5xQl4duNNyOUK7b8oMGucfsRUdjdf_3gTf6y5udSNF0wiJgGe3gBS_L5BnPeIsMAwmQFyy5qrGf-ZlXaP0-UFqU8w5gbt7hhX6xkh9Y6TeG4nip383dif94xwK2EGw8wNc_QelP3444wfobw5irvc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2681442488</pqid></control><display><type>article</type><title>Review of management priorities for invasive infections in people who inject drugs: highlighting the need for patient‐centred multidisciplinary care</title><source>Wiley</source><creator>Attwood, Lucy O ; McKechnie, Megan ; Vujovic, Olga ; Higgs, Peter ; Lloyd‐Jones, Martyn ; Doyle, Joseph S ; Stewardson, Andrew J</creator><creatorcontrib>Attwood, Lucy O ; McKechnie, Megan ; Vujovic, Olga ; Higgs, Peter ; Lloyd‐Jones, Martyn ; Doyle, Joseph S ; Stewardson, Andrew J</creatorcontrib><description>Summary
There has been a global increase in the burden of invasive infections in people who inject drugs (PWID).
It is essential that patient‐centred multidisciplinary care is provided in the management of these infections to engage PWID in care and deliver evidence‐based management and preventive strategies.
The multidisciplinary team should include infectious diseases, addictions medicine (inclusive of alcohol and other drug services), surgery, psychiatry, pain specialists, pharmacy, nursing staff, social work and peer support workers (where available) to help address the comorbid conditions that may have contributed to the patient’s presentation.
PWID have a range of antimicrobial delivery options that can be tailored in a patient‐centred manner and thus are not limited to prolonged hospital admissions to receive intravenous antimicrobials for invasive infections. These options include discharge with outpatient parenteral antimicrobial therapy, long‐acting lipoglycopeptides (dalbavancin and oritavancin) and early oral antimicrobials.
Open and respectful discussion with PWID including around harm reduction strategies may decrease the risk of repeat presentations with injecting‐related harms.</description><identifier>ISSN: 0025-729X</identifier><identifier>ISSN: 1326-5377</identifier><identifier>EISSN: 1326-5377</identifier><identifier>DOI: 10.5694/mja2.51623</identifier><identifier>PMID: 35754144</identifier><language>eng</language><publisher>Australia: John Wiley and Sons Inc</publisher><subject>Addiction ; Anti‐infective agents ; Bacterial infections ; Cardiovascular infections ; Drug Users ; Harm Reduction ; HIV Infections ; Humans ; Infectious Diseases ; Mental Disorders ; Narrative Review ; Pharmaceutical Preparations ; Pharmaceutical Services ; Research and Reviews ; Substance abuse, intravenous ; Substance Abuse, Intravenous - complications ; Substance Abuse, Intravenous - therapy ; Substance-Related Disorders</subject><ispartof>Medical journal of Australia, 2022-07, Vol.217 (2), p.102-109</ispartof><rights>2022 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of AMPCo Pty Ltd.</rights><rights>2022 The Authors. Medical Journal of Australia published by John Wiley & Sons Australia, Ltd on behalf of AMPCo Pty Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4203-53865661c89e3f15dd1ebc8dc8e857f7e6459c82f60e5f0ee106cd49fd19e9e93</citedby><cites>FETCH-LOGICAL-c4203-53865661c89e3f15dd1ebc8dc8e857f7e6459c82f60e5f0ee106cd49fd19e9e93</cites><orcidid>0000-0003-0447-7917</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,777,781,882,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35754144$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Attwood, Lucy O</creatorcontrib><creatorcontrib>McKechnie, Megan</creatorcontrib><creatorcontrib>Vujovic, Olga</creatorcontrib><creatorcontrib>Higgs, Peter</creatorcontrib><creatorcontrib>Lloyd‐Jones, Martyn</creatorcontrib><creatorcontrib>Doyle, Joseph S</creatorcontrib><creatorcontrib>Stewardson, Andrew J</creatorcontrib><title>Review of management priorities for invasive infections in people who inject drugs: highlighting the need for patient‐centred multidisciplinary care</title><title>Medical journal of Australia</title><addtitle>Med J Aust</addtitle><description>Summary
There has been a global increase in the burden of invasive infections in people who inject drugs (PWID).
It is essential that patient‐centred multidisciplinary care is provided in the management of these infections to engage PWID in care and deliver evidence‐based management and preventive strategies.
The multidisciplinary team should include infectious diseases, addictions medicine (inclusive of alcohol and other drug services), surgery, psychiatry, pain specialists, pharmacy, nursing staff, social work and peer support workers (where available) to help address the comorbid conditions that may have contributed to the patient’s presentation.
PWID have a range of antimicrobial delivery options that can be tailored in a patient‐centred manner and thus are not limited to prolonged hospital admissions to receive intravenous antimicrobials for invasive infections. These options include discharge with outpatient parenteral antimicrobial therapy, long‐acting lipoglycopeptides (dalbavancin and oritavancin) and early oral antimicrobials.
Open and respectful discussion with PWID including around harm reduction strategies may decrease the risk of repeat presentations with injecting‐related harms.</description><subject>Addiction</subject><subject>Anti‐infective agents</subject><subject>Bacterial infections</subject><subject>Cardiovascular infections</subject><subject>Drug Users</subject><subject>Harm Reduction</subject><subject>HIV Infections</subject><subject>Humans</subject><subject>Infectious Diseases</subject><subject>Mental Disorders</subject><subject>Narrative Review</subject><subject>Pharmaceutical Preparations</subject><subject>Pharmaceutical Services</subject><subject>Research and Reviews</subject><subject>Substance abuse, intravenous</subject><subject>Substance Abuse, Intravenous - complications</subject><subject>Substance Abuse, Intravenous - therapy</subject><subject>Substance-Related Disorders</subject><issn>0025-729X</issn><issn>1326-5377</issn><issn>1326-5377</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><recordid>eNp9kc9u1DAQxi0EotvChQdAPiKkLbEdOwkHpKrir4qQEEjcLNcZJ14ldrCTXfXGI_TEA_IkTHdLBRdkWTNjf_p5xh8hT1hxKlVTvhg3hp9Kpri4R1ZMcLWWoqruk1VRcLmuePPtiBznvMGSSV49JEdCVrJkZbkiPz_D1sOORkdHE0wHI4SZTsnH5GcPmbqYqA9bk_0WMHFgZx9DxpROEKcB6K6PWG3wgrZp6fJL2vuuH3DPPnR07oEGgHZPmgxCw_zrx7XFkPB0XIbZtz5bPw0-mHRFrUnwiDxwZsjw-DaekK9vXn85f7e--PT2_fnZxdqWvBA4Z62kUszWDQjHZNsyuLR1a2uoZeUqUKVsbM2dKkC6AoAVyrZl41rWAC5xQl4duNNyOUK7b8oMGucfsRUdjdf_3gTf6y5udSNF0wiJgGe3gBS_L5BnPeIsMAwmQFyy5qrGf-ZlXaP0-UFqU8w5gbt7hhX6xkh9Y6TeG4nip383dif94xwK2EGw8wNc_QelP3444wfobw5irvc</recordid><startdate>20220718</startdate><enddate>20220718</enddate><creator>Attwood, Lucy O</creator><creator>McKechnie, Megan</creator><creator>Vujovic, Olga</creator><creator>Higgs, Peter</creator><creator>Lloyd‐Jones, Martyn</creator><creator>Doyle, Joseph S</creator><creator>Stewardson, Andrew J</creator><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0447-7917</orcidid></search><sort><creationdate>20220718</creationdate><title>Review of management priorities for invasive infections in people who inject drugs: highlighting the need for patient‐centred multidisciplinary care</title><author>Attwood, Lucy O ; McKechnie, Megan ; Vujovic, Olga ; Higgs, Peter ; Lloyd‐Jones, Martyn ; Doyle, Joseph S ; Stewardson, Andrew J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4203-53865661c89e3f15dd1ebc8dc8e857f7e6459c82f60e5f0ee106cd49fd19e9e93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Addiction</topic><topic>Anti‐infective agents</topic><topic>Bacterial infections</topic><topic>Cardiovascular infections</topic><topic>Drug Users</topic><topic>Harm Reduction</topic><topic>HIV Infections</topic><topic>Humans</topic><topic>Infectious Diseases</topic><topic>Mental Disorders</topic><topic>Narrative Review</topic><topic>Pharmaceutical Preparations</topic><topic>Pharmaceutical Services</topic><topic>Research and Reviews</topic><topic>Substance abuse, intravenous</topic><topic>Substance Abuse, Intravenous - complications</topic><topic>Substance Abuse, Intravenous - therapy</topic><topic>Substance-Related Disorders</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Attwood, Lucy O</creatorcontrib><creatorcontrib>McKechnie, Megan</creatorcontrib><creatorcontrib>Vujovic, Olga</creatorcontrib><creatorcontrib>Higgs, Peter</creatorcontrib><creatorcontrib>Lloyd‐Jones, Martyn</creatorcontrib><creatorcontrib>Doyle, Joseph S</creatorcontrib><creatorcontrib>Stewardson, Andrew J</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Wiley Online Library Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Medical journal of Australia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Attwood, Lucy O</au><au>McKechnie, Megan</au><au>Vujovic, Olga</au><au>Higgs, Peter</au><au>Lloyd‐Jones, Martyn</au><au>Doyle, Joseph S</au><au>Stewardson, Andrew J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Review of management priorities for invasive infections in people who inject drugs: highlighting the need for patient‐centred multidisciplinary care</atitle><jtitle>Medical journal of Australia</jtitle><addtitle>Med J Aust</addtitle><date>2022-07-18</date><risdate>2022</risdate><volume>217</volume><issue>2</issue><spage>102</spage><epage>109</epage><pages>102-109</pages><issn>0025-729X</issn><issn>1326-5377</issn><eissn>1326-5377</eissn><abstract>Summary
There has been a global increase in the burden of invasive infections in people who inject drugs (PWID).
It is essential that patient‐centred multidisciplinary care is provided in the management of these infections to engage PWID in care and deliver evidence‐based management and preventive strategies.
The multidisciplinary team should include infectious diseases, addictions medicine (inclusive of alcohol and other drug services), surgery, psychiatry, pain specialists, pharmacy, nursing staff, social work and peer support workers (where available) to help address the comorbid conditions that may have contributed to the patient’s presentation.
PWID have a range of antimicrobial delivery options that can be tailored in a patient‐centred manner and thus are not limited to prolonged hospital admissions to receive intravenous antimicrobials for invasive infections. These options include discharge with outpatient parenteral antimicrobial therapy, long‐acting lipoglycopeptides (dalbavancin and oritavancin) and early oral antimicrobials.
Open and respectful discussion with PWID including around harm reduction strategies may decrease the risk of repeat presentations with injecting‐related harms.</abstract><cop>Australia</cop><pub>John Wiley and Sons Inc</pub><pmid>35754144</pmid><doi>10.5694/mja2.51623</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-0447-7917</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0025-729X |
| ispartof | Medical journal of Australia, 2022-07, Vol.217 (2), p.102-109 |
| issn | 0025-729X 1326-5377 1326-5377 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9539935 |
| source | Wiley |
| subjects | Addiction Anti‐infective agents Bacterial infections Cardiovascular infections Drug Users Harm Reduction HIV Infections Humans Infectious Diseases Mental Disorders Narrative Review Pharmaceutical Preparations Pharmaceutical Services Research and Reviews Substance abuse, intravenous Substance Abuse, Intravenous - complications Substance Abuse, Intravenous - therapy Substance-Related Disorders |
| title | Review of management priorities for invasive infections in people who inject drugs: highlighting the need for patient‐centred multidisciplinary care |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T23%3A20%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Review%20of%20management%20priorities%20for%20invasive%20infections%20in%20people%20who%20inject%20drugs:%20highlighting%20the%20need%20for%20patient%E2%80%90centred%20multidisciplinary%20care&rft.jtitle=Medical%20journal%20of%20Australia&rft.au=Attwood,%20Lucy%20O&rft.date=2022-07-18&rft.volume=217&rft.issue=2&rft.spage=102&rft.epage=109&rft.pages=102-109&rft.issn=0025-729X&rft.eissn=1326-5377&rft_id=info:doi/10.5694/mja2.51623&rft_dat=%3Cproquest_pubme%3E2681442488%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4203-53865661c89e3f15dd1ebc8dc8e857f7e6459c82f60e5f0ee106cd49fd19e9e93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2681442488&rft_id=info:pmid/35754144&rfr_iscdi=true |